Drug-Eluting Stent Payment Based On UK Prices Sets Precedent – MedPAC
This article was originally published in The Gray Sheet
Executive Summary
The Medicare Payment Advisory Commission expressed concern over the potential precedent set by the Centers for Medicare & Medicaid Services' recent decision to base the payment rate for drug-eluting stents on overseas prices
You may also be interested in...
Multiple Procedure Discount Will Not Apply To APC 225 – OPPS Final Rule
The status indicator for APC 225 (implantation of neurostimulator electrodes) will be changed to "S" for significant procedure, preventing it from receiving a multiple procedure discount, according to the 2003 hospital outpatient prospective payment system final rule
Multiple Procedure Discount Will Not Apply To APC 225 – OPPS Final Rule
The status indicator for APC 225 (implantation of neurostimulator electrodes) will be changed to "S" for significant procedure, preventing it from receiving a multiple procedure discount, according to the 2003 hospital outpatient prospective payment system final rule
New Technology Payment Rates Should Reflect Quality Of Life, Cost – Panel
CMS should consider a new medical technology's cost as well as its impact on quality of life in setting Medicare payment rates, according to an expert panel convened by Project HOPE